Mandate

Vinge advised Investor in connection with the IPO of Alligator

November 23, 2016

Alligator Bioscience AB (publ) was listed on the main market of Nasdaq Stockholm with the first day of trading being 23 November 2016. The price in the initial public offering was SEK 32.50 per share, corresponding to a total value of the company’s shares of approx. SEK 2,275 million. Investor AB, through Duba AB, was one of the two selling shareholders.
 
Vinge advised Investor. The Vinge team was headed by capital markets and public M&A partner Erik Sjöman.

Related

Vinge advises on the sale of Spring Media to Two Circles

The shareholders of Spring Media have entered into an agreement to sell the shares in Spring Media to Two Circles. Spring Media is an international sports agency operating in, among other things, production, packaging, digital strategies, and rights negotiations in the field of sports rights.
October 28, 2024

Vinge has advised Stendörren Fastigheter in connection with a directed share issue of approximately SEK 505 million

Vinge has advised the property company Stendörren Fastigheter AB (publ) in connection with a directed share issue through which the company raises proceeds of approximately SEK 505 million before transaction costs.
October 25, 2024

Vinge advises Main Capital and Aunetic in connection with the acquisition of Qnister

Vinge has advised Aunetic, a leading governance software specialist, in connection with the acquisition of Qnister AB (“Qnister”). The strategic acquisition enhances Aunetic’s product portfolio and strengthens its presence in the Swedish software compliance market.
October 25, 2024